JHSPH Center for Clinical Trials

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, JHSPH Center for Clinical Trials sits in the top decile of US sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count).

12 total trials 2 currently recruiting 8 completed later-stage tilt top decile by trial count

JHSPH Center for Clinical Trials: 12 sponsored US clinical trials, 2 recruiting.

JHSPH Center for Clinical Trials sponsors 12 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 8 completed. 11 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Macular Edema, with 2 trials.

Top-decile sponsor footprint

JHSPH Center for Clinical Trials ranks in the top decile of sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

12 total, page 1 of 1

RECRUITING NA

Early Intervention to Promote Cardiovascular Health of Mothers and Children

NCT06272045
RECRUITING Phase 3

Multi-Center Clean Air Randomized Controlled Trial in COPD

NCT06376994
ACTIVE NOT RECRUITING Phase 3

Natural Versus Programmed Frozen Embryo Transfer (NatPro)

NCT04551807
ACTIVE NOT RECRUITING Phase 3

Escitalopram for Agitation in Alzheimer's Disease

NCT03108846
COMPLETED Phase 3

Adalimumab vs. Conventional Immunosuppression for Uveitis Trial

NCT03828019
COMPLETED Phase 4

Losartan Effects on Emphysema Progression

NCT02696564
COMPLETED Phase 3

Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial

NCT02623426
COMPLETED Phase 3

PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial

NCT02374060
COMPLETED Phase 4

Study of Asthma and Nasal Steroids

NCT01118312
COMPLETED Phase 3

Citalopram for Agitation in Alzheimer's Disease

NCT00898807
COMPLETED Phase 4

Multicenter Uveitis Steroid Treatment (MUST) Trial

NCT00132691
COMPLETED Phase 4

The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial

NCT00156819

Phase Distribution

PhaseTrial count
Phase 3 7
Phase 4 4

Therapeutic Areas

Macular Edema 2
Uveitis 2
Chronic Obstructive Pulmonary Disease (COPD) 1
Emphysema 1
Preeclampsia 1
Cardiovascular Health 1
Dementia 1
Pregnancy Related 1

Where JHSPH Center for Clinical Trials enrollment is open (later-stage tilt)

2 recruiting of 12 indexed (17% open); 8 completed (67%).

Phase mix: 11 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top condition: Macular Edema (2 trials), 7 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

JHSPH Center for Clinical Trials: open-pipeline peers nationwide

Peers matched on 12 registered trials and 17% open enrollment, not the therapeutic-area sidebar.

JHSPH Center for Clinical Trials sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 468101214 0%5%10%15%20% Total trials Recruiting share JHSPH Center for Clinical TrialsAlachua Government ServicesAllergy TherapeuticsAmpio Pharmaceuticals.AngiodynamicsAdageneAgendiaAkamis BioAnthos Therapeutics
JHSPH Center for Clinical Trials sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

JHSPH Center for Clinical Trials sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 12 trials (± recruiting share)

Sponsors near 17% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this JHSPH Center for Clinical Trials page

12 registered trials is a research-attention snapshot, not an endorsement of JHSPH Center for Clinical Trials or any single study.

  • 2 of JHSPH Center for Clinical Trials's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Macular Edema is the condition JHSPH Center for Clinical Trials studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Macular Edema trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

JHSPH Center for Clinical Trials pipeline card: 12 registered trials from official public datasets.Report a data error.